p27^kip1 Deficiency Impairs G₂/M Arrest in Response to DNA Damage, Leading to an Increase in Genetic Instability

REFERENCES

• Bach, S. P., A. G. Renehan, and C. S. Potten. 2000. Stem cells: the intestinal stem cell as a paradigm. Carcinogenesis 21:469–476.
   PubMed Web of Science ®Google Scholar
• Bartek, J., and J. Lukas. 2001. Pathways governing G1/S transition and their response to DNA damage. FEBS Lett. 490:117–122.
   PubMed Web of Science ®Google Scholar
• Baumann, M., and H. P. Beck-Bornholdt. 1999. Hyperfractionated radiotherapy: tops or flops? Med. Pediatr. Oncol. 33:399–402.
   PubMedGoogle Scholar
• Cariello, N. F., and N. J. Gorelick. 1996. Database and software for the analysis of mutations at the lacI gene in both transgenic rodents and bacteria. Environ. Mol. Mutagen. 28:397–404.
   PubMedGoogle Scholar
• Catzavelos, C., N. Bhattacharya, Y. C. Ung, J. A. Wilson, L. Roncari, C. Sandhu, P. Shaw, H. Yeger, I. Morava-Protzner, L. Kapusta, E. Franssen, K. I. Pritchard, and J. M. Slingerland. 1997. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat. Med. 3:227–230.
   PubMed Web of Science ®Google Scholar
• Ch'ang, H. J., J. G. Maj, F. Paris, H. R. Xing, J. Zhang, J. P. Truman, C. Cardon-Cardo, A. Haimovitz-Friedman, R. Kolesnick, and Z. Fuks. 2005. ATM regulates target switching to escalating doses of radiation in the intestines. Nat. Med. 11:484–490.
   PubMed Web of Science ®Google Scholar
• Chibazakura, T., S. G. McGrew, J. A. Cooper, H. Yoshikawa, and J. M. Roberts. 2004. Regulation of cyclin-dependent kinase activity during mitotic exit and maintenance of genome stability by p21, p27, and p107. Proc. Natl. Acad. Sci. USA 101:4465–4470.
   PubMed Web of Science ®Google Scholar
• Ciaparrone, M., H. Yamamoto, Y. Yao, A. Sgambato, G. Cattoretti, N. Tomita, T. Monden, H. Rotterdam, and I. B. Weinstein. 1998. Localization and expression of p27KIP1 in multistage colorectal carcinogenesis. Cancer Res. 58:114–122.
   PubMed Web of Science ®Google Scholar
• de Boer, J. G., S. Provost, N. Gorelick, K. Tindall, and B. W. Glickman. 1998. Spontaneous mutation in lacI transgenic mice: a comparison of tissues. Mutagenesis 13:109–114.
   PubMedGoogle Scholar
• Dycaico, M. J., G. S. Provost, P. L. Kretz, S. L. Ransom, J. C. Moores, and J. M. Short. 1994. The use of shuttle vectors for mutation analysis in transgenic mice and rats. Mutat. Res. 307:461–478.
   PubMedGoogle Scholar
• Erfle, H. L., D. F. Walsh, J. Holcroft, N. Hague, J. G. de Boer, and B. W. Glickman. 1996. An efficient laboratory protocol for the sequencing of large numbers of lacI mutants recovered from Big Blue transgenic animals. Environ. Mol. Mutagen. 28:393–396.
   PubMedGoogle Scholar
• Fero, M. L., E. Randel, K. E. Gurley, J. M. Roberts, and C. J. Kemp. 1998. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 396:177–180.
   PubMed Web of Science ®Google Scholar
• Fero, M. L., M. Rivkin, M. Tasch, P. Porter, C. E. Carow, E. Firpo, K. Polyak, L. H. Tsai, V. Broudy, R. M. Perlmutter, K. Kaushansky, and J. M. Roberts. 1996. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27-deficient mice. Cell 85:733–744.
   PubMed Web of Science ®Google Scholar
• Fodde, R., W. Edelmann, K. Yang, C. van Leeuwen, C. Carlson, B. Renault, C. Breukel, E. Alt, M. Lipkin, and P. M. Khan. 1994. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc. Natl. Acad. Sci. USA 91:8969–8973.
   PubMed Web of Science ®Google Scholar
• Fredersdorf, S., J. Burns, A. M. Milne, G. Packham, L. Fallis, C. E. Gillett, J. A. Royds, D. Peston, P. A. Hall, A. M. Hanby, D. M. Barnes, S. Shousha, M. J. O'Hare, and X. Lu. 1997. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc. Natl. Acad. Sci. USA 94:6380–6385.
   PubMed Web of Science ®Google Scholar
• Kawamata, N., R. Morosetti, C. W. Miller, D. Park, K. S. Spirin, T. Nakamaki, S. Takeuchi, Y. Hatta, J. Simpson, and S. Wilcyznski. 1995. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res. 55:2266–2269.
   PubMed Web of Science ®Google Scholar
• Lee, M. G., C. J. Norbury, N. K. Spurr, P. Nurse, M. G. Lee, C. J. Norbury, N. K. Spurr, and P. Nurse. 1988. Regulated expression and phosphorylation of a possible mammalian cell-cycle control protein. Nature 333:676–679.
   PubMed Web of Science ®Google Scholar
• Loda, M., B. Cukor, S. W. Tam, P. Lavin, M. Fiorentino, G. F. Draetta, J. M. Jessup, and M. Pagano. 1997. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med. 3:231–234.
   PubMed Web of Science ®Google Scholar
• Loeb, L. A. 1991. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51:3075–3079.
   PubMed Web of Science ®Google Scholar
• Mori, M., K. Mimori, T. Shiraishi, S. Tanaka, H. Ueo, K. Sugimachi, and T. Akiyoshi. 1997. p27 expression and gastric carcinoma. Nat. Med. 3:593.
   PubMed Web of Science ®Google Scholar
• Nakayama, K., N. Ishida, M. Shirane, A. Inomata, T. Inoue, N. Shishido, I. Horii, and D. Loh. 1996. Mice lacking p27 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707–720.
   PubMed Web of Science ®Google Scholar
• Nakayama, K., H. Nagahama, Y. A. Minamishima, S. Miyake, N. Ishida, S. Hatakeyama, M. Kitagawa, S. Iemura, T. Natsume, and K. I. Nakayama. 2004. Skp2-mediated degradation of p27 regulates progression into mitosis. Dev. Cell 6:661–672.
   PubMed Web of Science ®Google Scholar
• Nishino, H., A. Knoll, V. L. Buettner, C. S. Frisk, Y. Maruta, J. Haavik, and S. S. Sommer. 1995. p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain. Oncogene 11:263–270.
   PubMedGoogle Scholar
• Noguchi, T., R. Kikuchi, K. Ono, S. Takeno, H. Moriyama, and Y. Uchida. 2003. Prognostic significance of p27/kip1 and apoptosis in patients with colorectal carcinoma. Oncol. Rep. 10:827–831.
   PubMedGoogle Scholar
• Ohtani, M., H. Isozaki, K. Fujii, E. Nomura, M. Niki, H. Mabuchi, K. Nishiguchi, M. Toyoda, T. Ishibashi, and N. Tanigawa. 1999. Impact of the expression of cyclin-dependent kinase inhibitor p27Kip1 and apoptosis in tumor cells on the overall survival of patients with non-early stage gastric carcinoma. Cancer 85:1711–1718.
   PubMedGoogle Scholar
• Oka, K., Y. Suzuki, and T. Nakano. 2000. Expression of p27 and p53 in cervical squamous cell carcinoma patients treated with radiotherapy alone: radiotherapeutic effect and prognosis. Cancer 88:2766–2773.
   PubMedGoogle Scholar
• Payne, S. R., and C. J. Kemp. 2003. p27(Kip1) (Cdkn1b)-deficient mice are susceptible to chemical carcinogenesis and may be a useful model for carcinogen screening. Toxicol. Pathol. 31:355–363.
   PubMedGoogle Scholar
• Philipp-Staheli, J., K. H. Kim, S. R. Payne, K. E. Gurley, D. Liggitt, G. Longton, and C. J. Kemp. 2002. Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice. Cancer Cell 1:355–368.
   PubMed Web of Science ®Google Scholar
• Philipp-Staheli, J., S. R. Payne, and C. J. Kemp. 2001. p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp. Cell Res. 264:148–168.
   PubMed Web of Science ®Google Scholar
• Pietenpol, J. A., S. K. Bohlander, Y. Sato, N. Papadopoulos, B. Liu, C. Friedman, B. J. Trask, J. M. Roberts, K. W. Kinzler, J. D. Rowley, et al. 1995. Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res. 55:1206–1210.
   PubMed Web of Science ®Google Scholar
• Ponce-Castaneda, M. V., M. H. Lee, E. Latres, K. Polyak, L. Lacombe, K. Montgomery, S. Mathew, K. Krauter, J. Sheinfeld, J. Massague, et al. 1995. p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res. 55:1211–1214.
   PubMed Web of Science ®Google Scholar
• Porter, P. L., K. E. Malone, P. J. Heagerty, G. M. Alexander, L. A. Gatti, E. J. Firpo, J. R. Daling, and J. M. Roberts. 1997. Expression of cell-cycle regulators p27 Kip-1 and cyclin E alone and in combination, correlate with survival in young breast cancer patients. Nat. Med. 3:222–225.
   PubMed Web of Science ®Google Scholar
• Potten, C. S. 2004. Radiation, the ideal cytotoxic agent for studying the cell biology of tissues such as the small intestine. Radiat. Res. 161:123–136.
   PubMed Web of Science ®Google Scholar
• Prakash, S., R. E. Johnson, L. Prakash, S. Prakash, R. E. Johnson, and L. Prakash. 2005. Eukaryotic translesion synthesis DNA polymerases: specificity of structure and function. Annu. Rev. Biochem. 74:317–353.
   PubMed Web of Science ®Google Scholar
• Rogakou, E. P., C. Boon, C. Redon, and W. M. Bonner. 1999. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 146:905–916.
   PubMed Web of Science ®Google Scholar
• Rogakou, E. P., D. R. Pilch, A. H. Orr, V. S. Ivanova, and W. M. Bonner. 1998. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273:5858–5868.
   PubMed Web of Science ®Google Scholar
• Sgambato, A., C. Ratto, B. Faraglia, M. Merico, R. Ardito, G. Schinzari, G. Romano, and A. R. Cittadini. 1999. Reduced expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in human colon cancer. Mol. Carcinog. 26:172–179.
   PubMed Web of Science ®Google Scholar
• Shamma, A., Y. Doki, T. Tsujinaka, H. Shiozaki, M. Inoue, M. Yano, K. Kawanishi, and M. Monden. 2000. Loss of p27(KIP1) expression predicts poor prognosis in patients with esophageal squamous cell carcinoma. Oncology 58:152–158.
   PubMed Web of Science ®Google Scholar
• Singh, S. P., J. Lipman, H. Goldman, F. H. Ellis, Jr., L. Aizenman, M. G. Cangi, S. Signoretti, D. S. Chiaur, M. Pagano, and M. Loda. 1998. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res. 58:1730–1735.
   PubMed Web of Science ®Google Scholar
• Sugihara, E., M. Kanai, S. Saito, T. Nitta, H. Toyoshima, K. Nakayama, K. I. Nakayama, K. Fukasawa, M. Schwab, H. Saya, and M. Miwa. 2006. Suppression of centrosome amplification after DNA damage depends on p27 accumulation. Cancer Res. 66:4020–4029.
   PubMedGoogle Scholar
• Suri, A., J. deBoer, W. Kusser, and B. W. Glickman. 1996. A 3 milliTesla 60 Hz magnetic field is neither mutagenic nor co-mutagenic in the presence of menadione and MNU in a transgenic rat cell line. Mutat. Res. 372:23–31.
   PubMed Web of Science ®Google Scholar
• Thomas, G. V., K. Szigeti, M. Murphy, G. Draetta, M. Pagano, and M. Loda. 1998. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Am. J. Pathol. 153:681–687.
   PubMed Web of Science ®Google Scholar
• Tsihlias, J., L. Kapusta, and J. Slingerland. 1999. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Annu. Rev. Med. 50:401–423.
   PubMed Web of Science ®Google Scholar
• Tutt, A. N., C. T. van Oostrom, G. M. Ross, H. van Steeg, and A. Ashworth. 2002. Disruption of Brca2 increases the spontaneous mutation rate in vivo: synergism with ionizing radiation. EMBO Rep. 3:255–260.
   PubMed Web of Science ®Google Scholar
• Wang, Y., and J. A. Heddle. 2004. Spontaneous and induced chromosomal damage and mutations in Bloom syndrome mice. Mutat. Res. 554:131–137.
   PubMedGoogle Scholar
• Wilson, J. W., D. M. Pritchard, J. A. Hickman, and C. S. Potten. 1998. Radiation-induced p53 and p21WAF-1/CIP1 expression in the murine intestinal epithelium: apoptosis and cell cycle arrest. Am. J. Pathol. 153:899–909.
   PubMed Web of Science ®Google Scholar
• Yang, W., L. Bancroft, J. Liang, M. Zhuang, and L. H. Augenlicht. 2005. p27kip1 in intestinal tumorigenesis and chemoprevention in the mouse. Cancer Res. 65:9363–9368.
   PubMedGoogle Scholar
• Yasui, W., Y. Kudo, S. Semba, H. Yokozaki, and E. Tahara. 1997. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas. Jpn. J. Cancer Res. 88:625–629.
   PubMedGoogle Scholar